Some babies whose mothers received an mRNA COVID-19 vaccine during pregnancy have been shown to develop virus-fighting antibodies by the time they reach six months in age, according to a research letter published Monday by the Journal of the American Medical Association (JAMA).
According to Reuters, the small study has not yet been peer-reviewed and only tracked a few dozen subjects. However, the findings offer hope that some children will develop tools to fight COVID-19 even though they’re not eligible to be vaccinated themselves.
According to the research letter, the study tracked a handful of women who got either the Pfizer or Moderna COVID-19 vaccine during their pregnancy. Those mothers all got their shots between 20 to 32 weeks gestation — when, according to Reuters, the transfer of maternal antibodies to the fetus via the placenta is at its highest.
Researchers followed up with 28 of those babies six months after birth and found that 16 — or 57% — had developed detectable antibodies that can fight COVID-19.
Read more at The Denver Channel.